News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
The perturbed genes will be identified by barcodes associated with single guide RNAs, and read using an in situ sequencing method.
Among the winners are a number of investigators who will receive funding to support omics-focused research.
The British CRISPR software developer is turning to investment platform SyndicateRoom as it looks to commercialize its products and expand into the US.
Thermo Fisher will sell Synthego's synthetic guide RNA products under the Invitrogen TrueGuide brand.
Researchers have used the gene-editing tool to disrupt a gain-of-function mutation in mice and human tissues that leads to glaucoma.
The New York Times reports that as China invests in science, it also is dealing with research fraud.
In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.
The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.
Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.